Search
for
Sort by
Research 91–120 of 1000+
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Ritlecitinib: First Approval
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Pharmacotherapy of alopecia areata
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Mechanisms regulating skin immunity and inflammation
- Differential impact of environmental factors on systemic and localized autoimmunity
- Potential Use of Spin Traps to Control ROS in Antipollution Cosmetics—A Review
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis
- Signaling pathways in hair aging
- Evaluation of the phenotypic, proliferative and secretory profile of mesenchymal stem cells from adipose tissue captured by laser-assisted liposuction
- Avaliação do perfil fenotípico, proliferativo e secretório de células-tronco mesenquimais do tecido adiposo captadas por lipoaspiração assistida por laser
- Keratin 17 modulates hair follicle cycling in a TN<i>Fα</i>-dependent fashion
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Orchestration of Mesenchymal Stem/Stromal Cells and Inflammation During Wound Healing
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Review of Promising Off-Label Use of Deucravacitinib
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid System
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- Niche-dependent immunometabolic regulation of tissue repair and regeneration
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata